X-18507113-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001323289.2(CDKL5):āc.17T>Cā(p.Ile6Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000644 in 1,087,577 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 23)
Exomes š: 0.0000064 ( 0 hom. 4 hem. )
Consequence
CDKL5
NM_001323289.2 missense
NM_001323289.2 missense
Scores
3
4
10
Clinical Significance
Conservation
PhyloP100: 6.71
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.29949898).
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.17T>C | p.Ile6Thr | missense_variant | 2/18 | ENST00000623535.2 | NP_001310218.1 | |
CDKL5 | NM_001037343.2 | c.17T>C | p.Ile6Thr | missense_variant | 3/22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.17T>C | p.Ile6Thr | missense_variant | 2/21 | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.17T>C | p.Ile6Thr | missense_variant | 2/18 | 1 | NM_001323289.2 | ENSP00000485244.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183320Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67776
GnomAD3 exomes
AF:
AC:
2
AN:
183320
Hom.:
AF XY:
AC XY:
1
AN XY:
67776
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000644 AC: 7AN: 1087577Hom.: 0 Cov.: 26 AF XY: 0.0000113 AC XY: 4AN XY: 353751
GnomAD4 exome
AF:
AC:
7
AN:
1087577
Hom.:
Cov.:
26
AF XY:
AC XY:
4
AN XY:
353751
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 09, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with CDKL5-related conditions. This variant is present in population databases (rs746036179, gnomAD 0.005%), including at least one homozygous and/or hemizygous individual. This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 6 of the CDKL5 protein (p.Ile6Thr). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T;.;.;.;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;D;D;D;.;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.;N;.;.;.;.;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;.;N;.;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
D;.;.;D;.;.;.;.;.
Sift4G
Uncertain
D;.;.;D;.;D;T;D;D
Polyphen
D;.;.;D;.;.;.;.;.
Vest4
MutPred
Loss of stability (P = 0.0344);Loss of stability (P = 0.0344);Loss of stability (P = 0.0344);Loss of stability (P = 0.0344);Loss of stability (P = 0.0344);Loss of stability (P = 0.0344);Loss of stability (P = 0.0344);Loss of stability (P = 0.0344);Loss of stability (P = 0.0344);
MVP
MPC
1.9
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at